|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/00 | (2006.01) |
| C07K 17/00 | (2006.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61K 51/10 | (2006.01) | ||
| C07K 16/28 | (2006.01) |
| (11) | Number of the document | 2905030 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15156647.8 |
| Date of filing the European patent application | 2009-08-11 | |
| (97) | Date of publication of the European application | 2015-08-12 |
| (45) | Date of publication and mention of the grant of the patent | 2019-11-06 |
| (46) | Date of publication of the claims translation | 2020-02-10 |
| (30) | Number | Date | Country code |
| 188548 P | 2008-08-11 | US |
| (72) |
Thudium, Kent B., US
Korman, Alan J., US
Leblanc, Heidi, US
Yamanaka, Mark, US
Selby, Mark, US
Zens, Kyra, D., US
|
| (73) |
E. R. Squibb & Sons, L.L.C.,
Route 206 & Province Line Road, Princeton, NJ 08540,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Žmogaus antikūnai, kurie suriša limfocitų aktyvacijos geną-3 (LAG-3), ir jų panaudojimas |
| Human antibodies that bind lymphocyte activation gene-3 (LAG-3) and uses thereof |
| Payment date | Validity (years) | Amount | |
| 2025-07-03 | 17 | 347.00 EUR |
| 2026-08-11 |